Literature DB >> 6417659

Characterization of the human receptor for T-cell growth factor.

W J Leonard, J M Depper, R J Robb, T A Waldmann, W C Greene.   

Abstract

Anti-Tac monoclonal antibody has been identified as a putative antibody against the receptor for T-cell growth factor (TCGF). We now show that: (i) TCGF blocks 85% of 3H-labeled anti-Tac binding to phytohemagglutinin-activated lymphoblasts and (ii) both anti-Tac and anti-TCGF immunoprecipitate a protein band that appears to represent TCGF crosslinked to its receptor on HUT-102B2 cells. In HUT-102B2 cells, the TCGF receptor is a Mr 50,000 glycoprotein with internal disulfide bond(s) and a pI of 5.5-6.0, and it represents approximately equal to 0.05% of total cellular de novo protein synthesis. It contains a peptide of Mr 33,000 that is processed to a mature form that includes N-linked and O-linked sugars and sialic acid.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417659      PMCID: PMC390105          DOI: 10.1073/pnas.80.22.6957

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Functional and morphologic characterization of human T cells continuously grown in vitro.

Authors:  F W Ruscetti; D A Morgan; R C Gallo
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

2.  Tunicamycin inhibition of polyisoprenyl N-acetylglucosaminyl pyrophosphate formation in calf-liver microsomes.

Authors:  J S Tkacz; O Lampen
Journal:  Biochem Biophys Res Commun       Date:  1975-07-08       Impact factor: 3.575

3.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

4.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

5.  Studies on T lymphocyte activation. I. Requirements for the mitogen-dependent production of T cell growth factors.

Authors:  J Andersson; K O Grönvik; E L Larsson; A Coutinho
Journal:  Eur J Immunol       Date:  1979-08       Impact factor: 5.532

6.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

7.  Identification of epidermal growth factor receptors in a hyperproducing human epidermoid carcinoma cell line.

Authors:  M M Wrann; C F Fox
Journal:  J Biol Chem       Date:  1979-09-10       Impact factor: 5.157

8.  A new staining technique for proteins in polyacrylamide gels using coomassie brilliant blue G250.

Authors:  R W Blakesley; J A Boezi
Journal:  Anal Biochem       Date:  1977-10       Impact factor: 3.365

9.  Role of carbohydrates in protein secretion and turnover: effects of tunicamycin on the major cell surface glycoprotein of chick embryo fibroblasts.

Authors:  K Olden; R M Pratt; K M Yamada
Journal:  Cell       Date:  1978-03       Impact factor: 41.582

10.  Multiple actins in Drosophila melanogaster.

Authors:  S J Horovitch; R V Storti; A Rich; M L Pardue
Journal:  J Cell Biol       Date:  1979-07       Impact factor: 10.539

View more
  57 in total

1.  An NMDA receptor ER retention signal regulated by phosphorylation and alternative splicing.

Authors:  D B Scott; T A Blanpied; G T Swanson; C Zhang; M D Ehlers
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

2.  Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.

Authors:  J E Crabtree; L D Juby; R V Heatley; A J Lobo; D W Bullimore; A T Axon
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

3.  Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex.

Authors:  M Tsudo; R W Kozak; C K Goldman; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

4.  Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro.

Authors:  R P Saneto; A Altman; R L Knobler; H M Johnson; J de Vellis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Intracytoplasmic phosphorylation sites of Tac antigen (p55) are not essential for the conformation, function, and regulation of the human interleukin 2 receptor.

Authors:  M Hatakeyama; S Minamoto; T Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

6.  Serum interleukin-2-receptor in coeliac disease: response to treatment and gluten challenge.

Authors:  J E Crabtree; R V Heatley; L D Juby; P D Howdle; M S Losowsky
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

7.  Longitudinal survey in an endemic region of plasma soluble interleukin-2 receptor and antibody levels in Plasmodium falciparum malaria.

Authors:  B F Chumpitazi; F Peyron; J Simon; C Boudin; I Sheick-Zakiuddin; S Picot; P Ambroise-Thomas
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

8.  Abnormal intracellular sorting of O-linked carbohydrate-deficient interleukin-2 receptors.

Authors:  K F Kozarsky; S M Call; S K Dower; M Krieger
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

9.  The interleukin 2 receptor (IL-2R): the IL-2R alpha subunit alters the function of the IL-2R beta subunit to enhance IL-2 binding and signaling by mechanisms that do not require binding of IL-2 to IL-2R alpha subunit.

Authors:  A J Grant; E Roessler; G Ju; M Tsudo; K Sugamura; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

10.  Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.

Authors:  T A Waldmann; W C Greene; P S Sarin; C Saxinger; D W Blayney; W A Blattner; C K Goldman; K Bongiovanni; S Sharrow; J M Depper
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.